The Global Genome Editing Market was worth USD 2.83 billion in 2016 and estimated to be growing at a CAGR of 14.42%, to reach USD 5.55 billion by 2021. Genome editing is the procedure of modifying DNA within a cell, accurately and efficiently in order to make an organism’s life functions enhanced. It is a form of genetic engineering wherein, DNA is inserted or replaced or even deleted from the genome of a living organism, using genetically engineered nucleases. It is a vital and emerging ... Read more
Also known as genome editing with engineered nucleases (GEEN), genome editing is a method of altering DNA within a cell in a safe manner. The technique is also used for removing, adding, or modifying DNA in the genome. By thus editing the genome, it is possible to change the primary characteristic features of an organism or a cell.
According to research report the global Genome Engineering Market is projected to be valued at USD 3.19 Billion in 2017 and is expected to grow at a CAGR of 14.5% to reach to USD 6.28 Billion by 2022. Lucrative North America markets to offer significant growth opportunities for the genome editing market in the coming years. This can be attributed to the development of gene therapy ... Read more
The Global Genome Editing Market size is estimated to reach USD 11.59 billion by 2027, from USD 4.36 billion in 2019, delivering a CAGR of 14.8% through the forecast period, according to a new report by Reports and Data. Genome editing refers to a genetic engineering method used for insertion, deletion, or modification in the genome of any organism. Genome editing has come up as promising tool with wide scale ... Read more
